A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell leukemia.

A new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond ...

As global temperatures rise, Cold Spring Harbor Laboratory (CSHL) scientists work to grow stronger, more resilient crops. Yet ...

The Vacaville City Council held a study session at Thursday evening’s Special City Council Meeting to receive an update from staff regarding economic development. Don Burrus, Director of ...

Discover why Crispr Therapeutics AG is a strong buy with FDA-approved Casgevy, a promising pipeline, and major growth ...

CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on ...

ABSTRACT: Gene editing technology, which allows for precise modifications to an organism’s genome, has emerged as a transformative tool in genetic engineering. This review introduces the fundamental ...

The "Biopharmaceuticals - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering. The global Biopharmaceuticals market is estimated at $412.1 billion in 2024 and is ...

Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where Verve Therapeutics, Inc. (NASDAQ:VERV) stands against the other CRISPR ...